Calles, May Queen .

HRN: 12-94-38  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2024
CEFUROXIME 1.5GM (VIAL)
10/10/2024
10/16/2024
IVT
900mg
Q8
Typhoid Fever
Waiting Final Action 
10/10/2024
CEFTRIAXONE 1G (VIAL)
10/10/2024
10/17/2024
IV
2g
OD
Typhoid Fever
Waiting Final Action 
10/10/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
10/10/2024
10/17/2024
PO
1ml
QID
Candidiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: